This invention relates to novel 1-hydroxyimino-3-phenyl-propanes of the formula
wherein R1 to R10 are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds are GPBAR1 agonists and may be used as medicaments for the treatment of diseases such as type II diabetes.
本发明涉及新型1-羟基
亚胺-3-苯基-
丙烷化合物,其
化学式为其中R1到R10如描述和索引中所定义,以及其药学上可接受的盐。这些化合物是GPBAR1激动剂,可用作治疗糖尿病II型等疾病的药物。